Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Health Catalyst Inc (NASDAQ: HCAT) closed at $8.32 in the last session, up 0.97% from day before closing price of $8.24. In other words, the price has increased by $0.97 from its previous closing price. On the day, 0.56 million shares were traded. HCAT stock price reached its highest trading level at $8.6 during the session, while it also had its lowest trading level at $8.06.
Ratios:
We take a closer look at HCAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 1.03 whereas as Long-Term Debt/Eq ratio is at 0.37.
On January 03, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $11.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $14.Barclays initiated its Overweight rating on January 03, 2024, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 05 ’24 when LeSueur Daniel sold 5,209 shares for $7.70 per share. The transaction valued at 40,127 led to the insider holds 129,690 shares of the business.
DANIEL LESUEUR bought 5,209 shares of HCAT for $40,005 on Nov 05 ’24. On Oct 15 ’24, another insider, Llewelyn Linda, who serves as the Chief People Officer of the company, sold 1,324 shares for $8.16 each. As a result, the insider received 10,804 and left with 114,275 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 506252832 and an Enterprise Value of 478460704. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.56 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 1.584 whereas that against EBITDA is -14.914.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $11.41, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is 2.80%, while the 200-Day Moving Average is calculated to be 11.90%.
Shares Statistics:
According to the various share statistics, HCAT traded on average about 476.38K shares per day over the past 3-months and 521110 shares per day over the past 10 days. A total of 60.85M shares are outstanding, with a floating share count of 58.33M. Insiders hold about 4.14% of the company’s shares, while institutions hold 88.38% stake in the company. Shares short for HCAT as of 1728950400 were 2610667 with a Short Ratio of 5.48, compared to 1726185600 on 2344086. Therefore, it implies a Short% of Shares Outstanding of 2610667 and a Short% of Float of 4.3999999999999995.
